Literature DB >> 8902842

Calcitonin promotes osteoclast survival in vitro.

K S Selander1, P L Härkönen, E Valve, J Mönkkönen, R Hannuniemi, H K Väänänen.   

Abstract

Inactivation of resorbing osteoclasts by calcitonin is associated with typical morphological changes and alteration of the specific organization of osteoclast cytoskeleton. Here we show that calcitonin also promotes the survival of rat osteoclasts in vitro, cultured either on glass or bone, by delaying the onset of apoptosis. Parathyroid hormone had no effect on osteoclasts cultured on glass but it slightly increased apoptosis index of osteoclasts cultured on bone. Calcitonin was also able to rescue osteoclasts in calvarial explant cultures. The survival effect of calcitonin was mimicked by dibutyryl cAMP and could not be blocked by various metabolic inhibitors known to affect the apoptotic pathway. However, clodronate-induced apoptosis of osteoclasts could not be reversed by calcitonin and neither could calcitonin rescue osteoclasts already committed to apoptosis. It did not alter the distribution of Bcl-2 in osteoclasts. Our results show that at least in vitro calcitonin protects osteoclasts from apoptosis and suggest that it regulates the onset of apoptosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8902842     DOI: 10.1016/0303-7207(96)03870-1

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  9 in total

Review 1.  Hormonal regulation of physiological cell turnover and apoptosis.

Authors:  R D Medh; E B Thompson
Journal:  Cell Tissue Res       Date:  2000-07       Impact factor: 5.249

2.  Calpain is required for normal osteoclast function and is down-regulated by calcitonin.

Authors:  Marilena Marzia; Riccardo Chiusaroli; Lynn Neff; Na-Young Kim; Athar H Chishti; Roland Baron; William C Horne
Journal:  J Biol Chem       Date:  2006-02-03       Impact factor: 5.157

Review 3.  Salmon calcitonin: a review of current and future therapeutic indications.

Authors:  C H Chesnut; M Azria; S Silverman; M Engelhardt; M Olson; L Mindeholm
Journal:  Osteoporos Int       Date:  2007-12-11       Impact factor: 4.507

4.  Increased bone mass is an unexpected phenotype associated with deletion of the calcitonin gene.

Authors:  Ana O Hoff; Philip Catala-Lehnen; Pamela M Thomas; Matthias Priemel; Johannes M Rueger; Igor Nasonkin; Allan Bradley; Mark R Hughes; Nelson Ordonez; Gilbert J Cote; Michael Amling; Robert F Gagel
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

5.  Calcitonin substitution in calcitonin deficiency reduces particle-induced osteolysis.

Authors:  Max D Kauther; Hagen S Bachmann; Laura Neuerburg; Martina Broecker-Preuss; Gero Hilken; Florian Grabellus; Gabriele Koehler; Marius von Knoch; Christian Wedemeyer
Journal:  BMC Musculoskelet Disord       Date:  2011-08-15       Impact factor: 2.362

6.  Reciprocal role of ERK and NF-kappaB pathways in survival and activation of osteoclasts.

Authors:  T Miyazaki; H Katagiri; Y Kanegae; H Takayanagi; Y Sawada; A Yamamoto; M P Pando; T Asano; I M Verma; H Oda; K Nakamura; S Tanaka
Journal:  J Cell Biol       Date:  2000-01-24       Impact factor: 10.539

7.  Regulation of cytochrome c oxidase activity by c-Src in osteoclasts.

Authors:  Tsuyoshi Miyazaki; Lynn Neff; Sakae Tanaka; William C Horne; Roland Baron
Journal:  J Cell Biol       Date:  2003-03-03       Impact factor: 10.539

8.  A novel ligand of calcitonin receptor reveals a potential new sensor that modulates programmed cell death.

Authors:  Sgb Furness; D L Hare; A Kourakis; A M Turnley; P J Wookey
Journal:  Cell Death Discov       Date:  2016-10-10

9.  Calcitonin inhibits SDCP-induced osteoclast apoptosis and increases its efficacy in a rat model of osteoporosis.

Authors:  Yi-Jie Kuo; Fon-Yih Tsuang; Jui-Sheng Sun; Chi-Hung Lin; Chia-Hsien Chen; Jia-Ying Li; Yi-Chian Huang; Wei-Yu Chen; Chin-Bin Yeh; Jia-Fwu Shyu
Journal:  PLoS One       Date:  2012-07-06       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.